B cell lymphoma

B cell lymphoma

any in a large group of non-Hodgkin's lymphomas characterized by malignant transformation of the B cells. See also non-Hodgkin's lymphoma.
enlarge picture
B-cell lymphoma

lymphoma, B cell

A malignant tumour found predominantly within the orbit and conjunctiva. Orbital lymphomas are the most common form of ocular lymphomas and cause proptosis and diplopia. They affect mainly adults and are primarily of the B cell/non-Hodgkin's type. Conjunctival lymphomas, also mainly of the B cell/non-Hodgkin's type, are seen in approximately 10% of systemic lymphoma patients. Clinically, conjunctival lymphomas appear salmon-pink in colour and have flat and smooth surfaces. There are several types of B cell lymphoma, one of them being Burkitt's lymphoma. Treatment is by radiotherapy.
References in periodicals archive ?
B cell lymphoma was out numbered (87%) than T cell lymphoma (13%).
5m, through the Therapy Acceleration Program, to help fund Kite's ongoing Phase 1/2 clinical study of KTE, which is designed to evaluate safety and efficacy in the treatment of patients with refractory diffuse large B cell lymphoma and two rare lymphomas primary mediastinal B cell lymphoma and transformed follicular lymphoma.
Primary B cell lymphoma of the penis: successful treatment with organ preservation.
To test that possibility, Tuse, Levy, and their colleagues used tobacco plants to make a fragment of an antibody from a mouse B cell lymphoma.
The neoplastic counterparts of these cells are the cell types observed in certain NHL subtypes, such as diffuse large B cell lymphoma and follicular lymphoma.
PET-negative pulmonary intravascular large B cell lymphoma diagnosed by a random transbronchial lung biopsy [published online ahead of print September 10, 2011].
With the scoring system, a definite diagnosis of low-grade B cell lymphoma of MALT is predicated on the existence of a dense, diffuse infiltrate of centrocyte-like cells/marginal zone cells in the lamina propria with prominent lymphoepithelial lesions.
Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced it has expanded its collaboration with Stanford University and University of Miami to continue the study of genetic biomarkers associated with treatment response and survival in diffuse large B cell lymphoma (DLBCL), the most common form of non-Hodgkin's lymphoma.
Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.
Success with this approach in the treatment of B cell lymphoma was recently reported in Nature Medicine.
The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing.